Cognitive Recovery Following Immune Effector Cell-Associated Neurotoxicity Syndrome in the First 6 Mo after Chimeric Antigen Receptor T-Cell Therapy
{{output}}
Chimeric antigen receptor T-cell (CAR-T) therapy is associated with immune effector cell-associated neurotoxicity syndrome (ICANS), which can manifest as acute and sub-acute cognitive dysfunction. Few studies have investigated cognitive recovery post-CAR-T the... ...
